NDC 50844-197 - Aspirin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50844-197
- Package NDCs from labels
- 50844-197-12
- Manufacturer
- L.N.K. International, Inc. | LNK International, Inc.
- Effective date
- 2019-08-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Quality Plus 44-157-NI-Delisted | L.N.K. International, Inc. | LNK International, Inc. | 2019-08-14 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Walmart Inc. | 1557bd9b-3e7c-4769-e063-6394a90a9d91 | 2025-11-04 | Warnings | R16CO5Y76E |
| Adult Low Dose Aspirin | ASPIRIN | Rising Pharma Holdings, Inc. | c3c4854e-726e-4926-b044-a5094943c306 | 2025-11-04 | Warnings | R16CO5Y76E |
| Systane Complete PF | PROPYLENE GLYCOL EMULSION | Alcon Laboratories, Inc. | 798ffdde-1dba-4a3f-a0b6-937f9e958cca | 2025-11-03 | Warnings | 6DC9Q167V3 |
| Ascomp with Codeine | BUTALBITAL, ASPIRIN, CAFEINE, AND CODEINE PHOSPHATE | LGM PHARMA SOLUTIONS, LLC | 1cab3106-1064-4b42-892b-39f405d9e02f | 2025-11-01 | Boxed warning, Warnings, Adverse reactions | R16CO5Y76E |
| Physicians Care Aspirin | ASPIRIN | Acme United Corporation | aa67ea3a-2741-7ee0-e053-2a95a90a6485 | 2025-10-31 | Warnings | R16CO5Y76E |
| GOODYS Hangover | ASPIRIN AND CAFFEINE | Medtech Products Inc. | 0b0067e0-58b0-4581-aa4b-e398c32c559a | 2025-10-23 | Warnings | R16CO5Y76E |
| GOODYS Extra Strength Headache Mixed Fruit Blast | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Medtech Products Inc. | 6cb758bf-5a50-46bb-96e7-65b810b12de0 | 2025-10-23 | Warnings | R16CO5Y76E |
| Advanced Eye Relief Dry Eye Rejuvenation | GLYCERIN PROPYLENE GLYCOL | Bausch & Lomb Incorporated | 027969ee-64e4-4b08-bab7-c4cc8ed22f5f | 2025-10-23 | Warnings | 6DC9Q167V3 |
| Anacin | ASPRIN AND CAFFEINE | Insight Pharmaceuticals LLC | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 2025-10-23 | Warnings | R16CO5Y76E |
| Goodys Back and Body Pain | ACETAMINOPHEN AND ASPRIN | Medtech Products Inc. | 055d0288-61d4-48bc-b91f-6ecc1969beb8 | 2025-10-23 | Warnings | R16CO5Y76E |
| Goodys Cool Orange Headache | ACETAMINOPHEN AND ASPIRIN AND CAFFEINE | Medtech Products Inc. | 31212c97-9975-427e-bc3d-f7125f30299a | 2025-10-23 | Warnings | R16CO5Y76E |
| BC Arthritis | ASPIRIN AND CAFFEINE | Medtech Products Inc. | 3a85be2d-6548-4de5-8109-60e1ca2bfca3 | 2025-10-23 | Warnings | R16CO5Y76E |
| Goodys Extra Strength | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Medtech Products Inc. | d4325b17-23bc-44ac-868d-bb0886853a73 | 2025-10-23 | Warnings | R16CO5Y76E |
| BC | ASPIRIN AND CAFFEINE | Medtech Products Inc. | 226173d4-b6d5-4fe6-b24e-1cc5d1b31c88 | 2025-10-23 | Warnings | R16CO5Y76E |
| BC MAX | ASPIRIN, ACETAMINOPHEN, CAFFEINE | Medtech Products Inc. | 1e2a07ab-23e6-49b4-a676-212dc6880f14 | 2025-10-23 | Warnings | R16CO5Y76E |
| Ecotrin Regular Strength | ASPIRIN | Medtech Products Inc. | 36cb530b-25b2-4f62-a25d-aa04360815a8 | 2025-10-23 | Warnings | R16CO5Y76E |
| Acetaminophen, Aspirin, Caffeine | ACETAMINOPHEN, ASPIRIN, CAFFEINE | CVS Pharmacy, Inc. | 6deb854f-863e-24ad-e053-2991aa0afb17 | 2025-10-21 | Warnings | R16CO5Y76E |
| Walgreens Antacid Pain Relief Extra Strength | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walgreens | b60df498-07db-500b-e053-2a95a90aff6a | 2025-10-17 | Warnings | R16CO5Y76E |
| Equate Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walmart | 6271b34b-55a0-40a8-e053-2a91aa0acb22 | 2025-10-17 | Warnings, Adverse reactions | R16CO5Y76E |
| Orphenadrine Citrate, Aspirin and Caffeine | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | Atland Pharmaceuticals, LLC | 7776aae6-3cbd-4aed-9aac-4bed80339e27 | 2025-10-17 | Warnings, Adverse reactions | R16CO5Y76E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.